Tag Archives: biopharma

“Troubleshooting” a Key Challenge of the Global Branding Process for New Bio-Pharma Products: Alignment Across Geographies

In the bio-pharmaceutical industry, it is no secret that different regions of the world have diverse regulatory and cultural environments. What is less apparent is that given these regional regulatory and cultural differences, pharmaceutical companies can have an effective global

Best Practices Hosting 6th Medical Affairs Consortium on HEOR

Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable

One Way to Please the Boss (& the Boss’s Boss): Crafting Highly Effective Executive Briefs

A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector.  As a

Top Trends in 2015 – Is Your Organization Prepared?

2015 is here & with the New Year comes many new trends and topics of discussion. With the increasing importance of payers and high demand on evidence-based information, it is clear that there are many shifts happening in the pharmaceutical,

Internal Communication Commandments to Live By

In order to improve an organization as a whole, it is critical to improve internal corporate communications. Best Practices, LLC’s work highlights how companies deliver their internal messages and find the proper balance between informing and educating employees. We have seen companies

Best Practices in Lifecycle Management: Maximizing the Potential of Mature Brands

As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to

Big Data in Pharma: What is Big Data?

We are past the peak of the Big Data hypecycle, not least of all because about half of the content on the topic put out by marketing gurus, branding experts, and other non-practitioners has moved on from extolling Big Data

Pharma Companies Feeling the Heat From the Sunshine Act

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,

Thou Shalt Build Credibility But Plan for the Worst

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and

Developing & Maintaining Strategic Professional & Trade Relations Functions

Professional and trade relations groups are critical for dealing with a company’s critical stakeholder groups, such as professional, payer, and patient organizations. Despite this, these groups still must show value within healthcare organizations, while external trends are constantly shaping the

SPECIAL: 2014-2015 Medical Affairs Consortium Survey Has Launched

As the healthcare landscape changes, the Medical Affairs function has begun to play increasingly important roles in clinical development, market education, and regulatory compliance. Now, more than ever, leaders can learn valuable lessons from their peers on how they overcome

New Technologies Creating New Public Relations Opportunities

While marketers in the biopharmaceutical industry have long used Public Relations as a tool to support their brands, recent technologies –social networks, audio sharing, and video sharing—are creating fertile new ground for PR experts. These new additions to the Public

Utilizing Automation & Outsourcing to Maximize Market Research Effectiveness

Outsourcing and automation are cost-saving tactics that many pharmaceutical and biotechnology companies are increasingly utilizing. In today’s dynamic biopharmaceutical marketplace, where consumer needs have no boundaries, tactics such as outsourcing and automation can provide sustainable and efficient function options, especially

Optimizing Marketing Staff Levels to Drive Growth

In today’s tough economy, maintaining operational efficiencies remains key, even while focusing on strategy and tactics to drive growth and profitability. Commercial bio-pharma companies must also achieve challenging profitability rates in order to meet investor expectations. By understanding the best